We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDH
RNS Number : 4890U
Immunodiagnostic Systems Hldgs PLC
18 January 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------------------------- 1. Identity of the issuer or Immunodiagnostic Systems the underlying issuer Holdings PLC of existing shares to which GB00B01YZ052 voting rights are attached: (ii) ------------------------------------------------------------- ---------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ---------------------------------------------------------------- ------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------- ------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------- ------------------------- An event changing the breakdown of voting rights ---------------------------------------------------------------- ------------------------- Other (please specify): ------------------------------------------------------- ------- ------------------------- 3. Full name of person(s) Norges Bank subject to the notification obligation: (iii) --------------------------------------------------------- -------------------------------- 4. Full name of shareholder(s) N/A (if different from 3.):(iv) --------------------------------------------------------- -------------------------------- 5. Date of the transaction 17 January 2017 and date on which the threshold is crossed or reached: (v) --------------------------------------------------------- -------------------------------- 6. Date on which issuer 18 January 2017 notified: --------------------------------------------------------- -------------------------------- 7. Threshold(s) that is/are Below 4% crossed or reached: (vi, vii) --------------------------------------------------------- -------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- --------------- --------------- -------------- -------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ----------- -------------- ------------ ------------ ------------ ----------- 3.54 GB00B01YZ052 1,199,698 1,199,698 1,041,937 1,041,937 % --------------- --------------- -------------- ------------ ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------- ---------------------------- --------------------- N/A N/A N/A N/A N/A ----------------- ------------- ------------------------------- ---------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- ------------- ---------------- ---------------------------- ----------------------- N/A N/A N/A N/A N/A Nominal Delta --------------- ------------- ------------- ---------------- ---------------------------- ------------ --------- N/A N/A ------------- ----------- ----------- ------------ ---------- ------------ ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- ------------------------------------------------------------------- 1,041,937 3.54 % ------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------ N/A Proxy Voting: ------------------------------------------------------------------ 10. Name of the proxy holder: Norges Bank ---------------------------------------------- ------------------ 11. Number of voting rights proxy N/A holder will cease to hold: ---------------------------------------------- ------------------ 12. Date on which proxy holder will N/A cease to hold voting rights: ---------------------------------------------- ------------------ 13. Additional information: None ---------------------------------------------- ------------------ 14. Contact name: Philippe Chiaroni ---------------------------------------------- ------------------ 15. Contact telephone number: +4724073297 ---------------------------------------------- ------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWUURBOAAAAR
(END) Dow Jones Newswires
January 18, 2017 07:26 ET (12:26 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions